A team of 15 lawyers across four different Norton Rose Fulbright offices in the US have decamped to join Reed Smith. The team includes global head of life sciences and healthcare Rick Robinson, Washington partner Lesley Reynolds, Austin partners Jeff Layne and Ben Koplin and New York partner Cori Goldberg. Two Norton Rose associates, Washington […]
Linklaters is acting for Takeda Pharmaceuticals in the ongoing tussle for Irish drug maker Shire, represented by Slaughter and May.
Freshfields Bruckhaus Deringer is advising Advent International on its potential €2bn deal with French pharmaceuticals company Sanofi.
McDermott Will & Emery has hired a life sciences team in Frankfurt from Dechert, which just yesterday saw a team decamp from its London office for Goodwin Procter. The team is being led by partner Rüdiger Herrmann, who joined Dechert in 2014 from WilmerHale. He was also a partner at Mayer Brown between 2001 and […]
As a former chemistry student, Hogan Lovells IP partner Daniel Brook has honed his legal and science knowledge to become indispensable to several of the world’s largest pharmaceutical companies looking to safeguard their products. One of the most important judgments last year was Eli Lilly’s landmark patent trial against pharmaceutical rival Actavis. Brook took the […]
Most say the reason they work additional unpaid hours is because the solicitor does less than previously.
Taylor Wessing‘s co-head of international litigation Shane Gleghorn has been announced as the firm’s new managing partner. Gleghorn will take up the role on 1 October, replacing Tim Eyles. Last December, The Lawyer revealed Eyles would step down in June 2018 at the conclusion of his third term at the helm of the firm. Eyles […]
Matrix Chambers has launched a new chambers-wide initiative designed to involve its barristers at an earlier stage to provide impartial advice during regulatory investigations. Integrity+ is a new service available to clients which will see Matrix barristers provide objective advice on issues such as the correct choice of law firm or accountant representation in the first […]
Emerging markets investment firm Leapfrog Investments has hired a new general counsel, three months after GC and Linklaters corporate partner Stuart Bedford exited to return to full-time private practice. Leapfrog has appointed Frances Holliday, who was general counsel at asset manager Kazimir Partners, to oversee the legal function of the London-based company. Holliday previously spent nearly a […]
Browne Jacobson has grown its top line by 9.2 per cent, rising from £66.8m to £73m in the 2017/18 financial year and mirroring its performance in 2015/16. With last year’s results, the firm has now grown its top line by £23m, or 46 per cent, since 2012/13 and its eighth consecutive year of revenue growth. […]
UBS EMEA head of litigation Susy Bullock is deliberating whether to formalise a legal panel for the investment bank’s work in the region to mirror those already in place the Americas and Asia Pacific. The panel would be Bullock’s first in the role after having joined UBS from Gibson Dunn & Crutcher as an associate […]
Clifford Chance has refocused its global innovation strategy around expanding on its network of innovation and delivery hubs around the world, The Lawyer can reveal. The hubs in Singapore, New York, Dubai and London will focus on key innovation points for the firm and will work alongside resource management, pricing and pitching support teams as well as assisting […]
Linklaters heavyweight M&A partner Roger Barron is exiting the firm after 17 years to join Paul Hastings in London. This move comes exactly a week after Paul Hastings announced the hire of DLA Piper partner Anu Balasubramanian. Barron featured in The Lawyer Hot 100 2018, sealing his place in this year’s Hot 100 following his work closing […]
Clifford Chance is searching for its first global head of inclusion and diversity, just a few weeks after the firm revealed a 66 per cent pay gap in its gender pay gap reporting. Clifford Chance’s new global head of diversity and strategy will be based in any of the firm’s 32 worldwide offices, and will work […]
One recent legal development in the pharmaceutical field is the change of methodology for establishing prices for medicinal products which are totally or partially paid for by the social security system. However, already representatives from associations of medicine producers are pushing for this methodology to be revised, claiming that its overall impact on the market […]
By Henry A Harris and Stephen Franchetto With the Cannabis Act (Bill C 45) set to be voted on by the Senate of Canada in two weeks (June 7, 2018) and legalization of marijuana expected in the coming months, Canada’s largest cannabis company today became the first marijuana producer to be approved for listing on the […]
By Dr Simon Fox QC The last year has seen a number of significant cases as clinical negligence law continues to evolve. Some, but not all, demonstrate how it can be easier for a Claimant to succeed, with Montgomery showing its influence in areas other than consent. The following is a summary of the important […]
By Jon-Paul Powers and William Bjornsson The use of probiotics in foods in Canada has become commonplace but current policy toward probiotic claims is limited. For food producers willing to engage, Health Canada’s Food Directorate can provide helpful premarket guidance…
By Megan Martins Further to our previous article on the subject, the Government of Canada is pushing ahead with its plan to restrict the marketing of unhealthy foods and beverages to kids…
This briefing covers the following: General Medicinal Product and its advertising Providing Information prior to Medicinal Product Authorisation Advertisement to Healthcare Professionals Gifts and Financial Incentives General Advertising
At the Pharmaceutical Forum of the EAEU and CIS countries held in Moscow in late February 2018, the Director of the Department of Technical Regulation and Accreditation of the Eurasian Economic Commission (EEС) said that the full-scale work on registration of medicines using the unified information system of the Eurasian Economic Union (EAEU) will start […]
Whilst it is not possible to eliminate acrylamide completely from foods, it is possible to take steps to try and ensure that acrylamide levels are as low as reasonably possible. This is the reasoning behind the new Commission Regulation (EU) 2017/2158 which came into force this month. As from 11 April 2018, all food business […]
Public Health England (PHE) is an executive agency of the Department of Health and its remit is to address health inequalities and promote health and well-being. One priority for 2018 is to “support people to make healthy choices” and it has resolved to deliver a programme of work which significantly reduces childhood obesity. Although its […]
The Competition Appeal Tribunal (CAT) recently gave judgment in the long-awaited appeals by GSK and five generic pharmaceutical companies (Generics (UK) Ltd, Xellia Pharmaceuticals ApS, Alpharma LLC, Actavis UK Ltd and Merck KGaA) against a decision by the Competition and Markets Authority (CMA) to impose fines of almost £45m in total for alleged “pay for […]
By Mamta Gupta The litigation of vaginal mesh is becoming more and more widespread. This may be as a result of increasing awareness of the complications that can arise post mesh which is borne out by the media storm in the past year, along with the highprofile presence of antimesh campaigners such as Sling the […]
The number of medical malpractice litigation cases in Romania is growing exponentially. It is a phenomenon that directly involves insurance companies, since professional liability insurance covering malpractice is mandatory for doctors. This trend can be explained by the collapsing Romanian healthcare system…
